WO2012136204A3 - Préparation ou complément alimentaire - Google Patents

Préparation ou complément alimentaire Download PDF

Info

Publication number
WO2012136204A3
WO2012136204A3 PCT/DE2012/100090 DE2012100090W WO2012136204A3 WO 2012136204 A3 WO2012136204 A3 WO 2012136204A3 DE 2012100090 W DE2012100090 W DE 2012100090W WO 2012136204 A3 WO2012136204 A3 WO 2012136204A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
glutathione
improving
acetaldehyde
alcohol metabolism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/DE2012/100090
Other languages
German (de)
English (en)
Other versions
WO2012136204A2 (fr
Inventor
Gunnar Frank
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO2012136204A2 publication Critical patent/WO2012136204A2/fr
Publication of WO2012136204A3 publication Critical patent/WO2012136204A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Préparation pharmaceutique ou complément alimentaire destinés à l'amélioration du métabolisme de l'alcool. Pour obtenir une dégradation particulièrement efficace de l'acétaldéhyde, ladite préparation contient, en tant que constituant essentiel, du glutathion et/ou des substances à partir desquelles le corps synthétise le glutathion. La conversion enzymatique est ainsi considérablement accélérée ou catalysée, sans qu'il se produise une réaction chimique directe du glutathion avec l'acétaldéhyde. Il est apparu que la vitesse de dégradation de l'acétaldéhyde peut être considérablement augmentée de cette manière, si bien que les effets secondaires indésirables sont notablement diminués ou disparaissent au bout d'un court laps de temps.
PCT/DE2012/100090 2011-04-04 2012-04-03 Préparation ou complément alimentaire Ceased WO2012136204A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102011001768.2 2011-04-04
DE102011001768A DE102011001768A1 (de) 2011-04-04 2011-04-04 Präparat oder Nahrungsergänzungsmittel

Publications (2)

Publication Number Publication Date
WO2012136204A2 WO2012136204A2 (fr) 2012-10-11
WO2012136204A3 true WO2012136204A3 (fr) 2012-12-27

Family

ID=46201055

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2012/100090 Ceased WO2012136204A2 (fr) 2011-04-04 2012-04-03 Préparation ou complément alimentaire

Country Status (2)

Country Link
DE (1) DE102011001768A1 (fr)
WO (1) WO2012136204A2 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030211172A1 (en) * 2002-05-10 2003-11-13 Jones Jeremy Park Composition and method for substantially reducing the deleterious effects of alcohol on the body
US20090104313A1 (en) * 2007-10-18 2009-04-23 Brian Lottig Nutrient-enhanced alcoholic beverage formulations and methods of making the same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4450153A (en) 1982-09-30 1984-05-22 Phillips Petroleum Company Alcohol removal from blood with alcohol oxidase
AT394493B (de) * 1989-05-11 1992-04-10 Homosan Ag Pharmazeutisches praeparat zur behandlung von lebererkrankungen
FI20021819A0 (fi) 2002-10-14 2002-10-14 Pekka Untamo Heino Valmiste alkoholin metabolian tehostamiseksi
FI122914B (fi) 2005-04-01 2012-08-31 Biohit Oyj Elintarvikekoostumus asetaldehydin sitomiseksi suussa ja ruoansulatuskanavassa ja menetelmä koostumuksen valmistamiseksi
DK1909600T3 (da) * 2005-07-29 2012-07-30 Tima Foundation Sammensætning til moderering af alkoholmetabolisme og til at reducere risikoen for alkoholforårsagede sygdomme
FI20060501A7 (fi) 2006-05-22 2007-11-23 Biohit Oyj Koostumus ja menetelmä asetaldehydin sitomiseksi mahalaukussa
EP1982604A1 (fr) * 2007-04-20 2008-10-22 Naturheilzentrum Allgäu Complément alimentaire destiné à équilibrer les carences alimentaires
DE102011008478A1 (de) * 2010-01-29 2011-08-04 Müller-Schulte, Detlef, Dr., 52066 Ganzheitliches Nahrungsergänzungsmittel

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030211172A1 (en) * 2002-05-10 2003-11-13 Jones Jeremy Park Composition and method for substantially reducing the deleterious effects of alcohol on the body
US20090104313A1 (en) * 2007-10-18 2009-04-23 Brian Lottig Nutrient-enhanced alcoholic beverage formulations and methods of making the same

Also Published As

Publication number Publication date
WO2012136204A2 (fr) 2012-10-11
DE102011001768A1 (de) 2012-10-04

Similar Documents

Publication Publication Date Title
WO2012056457A3 (fr) COMPOSITIONS ET PROCÉDÉS D'ACTIVATION D'EXPRESSION PAR UN ARNmi ENDOGÈNE SPÉCIFIQUE
WO2012075103A3 (fr) Accélération du vieillissement de boissons à base d'éthanol
WO2013052907A3 (fr) Méthodes et procédés pour évaluation non invasive de variations génétiques
WO2012018881A3 (fr) Procédés et compositions pour la régulation d'arn
WO2011041584A3 (fr) Procédés de modulation de l'autophagie par la modulation de produits géniques renforçant l'autophagie
WO2009137674A3 (fr) Traitement des maladies de la myéline au moyen de préparations cellulaires optimisées
WO2012129084A3 (fr) Inhibiteurs de la glucosylcéramide synthase
WO2011018423A3 (fr) Dispositif et procédé destinés au traitement de cellules vivantes au moyen d'un plasma
WO2009089494A3 (fr) Compositions pharmaceutiques
PL2453006T3 (pl) Sposób wytwarzania l-lizyny przy użyciu corynebacterium sp. która uzyskała aktywność dehydrogenazy gliceraldehydo-3-fosforanowej pochodzącej od obcych gatunków
WO2012058494A3 (fr) Variantes d'isoprène synthase pour l'augmentation de la production d'isoprène
WO2014028429A3 (fr) Enzymes et polymérases destinées à la synthèse d'arn
WO2009089593A8 (fr) Procédé de préparation de produits nutritionnels, thérapeutiques ou organoleptiques à partir de glycérol brut
WO2010111344A3 (fr) Procédés et microorganismes pour la production d'acides dicarboxyliques en c4
PL2478910T3 (pl) Środek przeciwko otyłości, żywność lub napój przeciwko otyłości, środek poprawiający tolerancję glukozy i żywność lub napój poprawiające tolerancję glukozy
WO2010123728A3 (fr) Procédé de fabrication et d'utilisation de substrats revêtus contenant du charbon actif et produits obtenus à partir de ceux-ci
WO2012006014A3 (fr) Agents pharmaceutiques multicomposants pour traiter le diabète
BRPI0814603A2 (pt) Processo para produzir maltobionato, uso de maltobionato, e, métodos para prevenir oxidação durante um processo de produção de alimentos ou rações, e para prevenir oxidação em um produto alimentício ou de ração
MX349801B (es) Sustratos de enzimas de ácido nucleico.
WO2010136104A3 (fr) Agents antipelliculaires
WO2013003689A3 (fr) Compositions contenant des nitro-acides gras
WO2010119424A3 (fr) Composition destinee a la regulation du metabolisme des lipides
WO2013018091A8 (fr) Particules destinées au traitement de maladies neurodégénératives
WO2012173358A3 (fr) Cellules souches pluripotentes issues de cellules somatiques du testicule, procédé de production de celles-ci, et composition pharmaceutique pour le traitement de l'impuissance comprenant celles-ci
WO2013100718A3 (fr) Composition pharmaceutique permettant de prévenir ou de traiter des maladies inflammatoires ou l'asthme, contenant un extrait de lagerstroemia ovalifolia ou une fraction de celle-ci en tant que principe actif

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12724874

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 12724874

Country of ref document: EP

Kind code of ref document: A2